About the Phase I program

The doctors in our Phase I Program match patients to the best clinical trial for their needs. We do not use a placebo, so every patient receives the therapy that’s best for them. Our program includes:

  • Expert team: Our Phase I Program features leading researchers and board-certified medical oncologists with decades of experience in cancer treatment. Specialized nurses and research coordinators support patients throughout the trials and provide regular updates to referring physicians.
  • Novel therapies: The Phase I clinical trials in our clinic offer latest innovations in cancer care. These promising new treatments are offered at only a few cancer centers worldwide.
  • Precision medicine: Many of our Phase I trials feature therapies that are customized for a person’s genetics. With this approach, we treat both rare and common tumors with personalized care that addresses the patient’s unique needs.
  • Safety: Our team follows patients closely to ensure their well-being throughout the trial. We monitor the treatment’s efficacy and manage any side effects.
  • Focus on diversity: Through our clinic, we reach out to people with various ethnic, financial and medical backgrounds in our community. We’re studying how these therapies work in a diverse group of people, advancing cancer care in our community and across the world.

Our location

The Phase I program is located at Inova Schar Cancer in Fairfax on the fifth floor. For additional questions, please call us at 571-472-4724.

We look forward to hearing from you.
 

Meet our Phase I team

Janakiraman Subramanian, MD

Early Developmental Therapeutics Program Faculty

Raymond Wadlow, MD

Early Developmental Therapeutics Program Faculty
Safae Chouraichi, PharmD

Safae Chouraichi, PharmD

Manager of Research Pharmacy
Stephanie Van Bebber

Stephanie Van Bebber

Senior Director of Clinical Trials